BioSpace News Archive

Genetown

Concert Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 9, 2017, and Participate at Upcoming Investor Conferences

The Company will host a conference call and webcast at 8:30 a.m. EST to discuss third quarter financial results and provide a business update.

November 2, 2017

·

2 min read

Business

Sectra Enters the Philippines by Signing Medical Imaging Distribution Agreement With Medical One

“This distribution agreement with Medical One will enable us to address these demands by combining their market-specific expertise with our extensive experience in delivering scalable solutions that cover multiple enterprises in large geographic areas--within teleradiology and telepathology specifically.”

November 2, 2017

·

3 min read

Drug Development

Betagenon/Baltic Bio Announces Positive Results From a 28-day Phase IIa Trial of the First-in-class AMPK Activator O304 in Type 2 Diabetics

Review of the initial data showed that a number of patients who were included based on HbA1c at screening, had FPG below 7 mM or above 13.3 mM at day 1, and that the data analysis of FPG required a post hoc analysis plan.

November 2, 2017

·

4 min read

Bio NC

Male Contraception Initiative Awards $500K Research Grant to Vibliome Therapeutics, Inc., for the Development of a New Contraceptive Product

The project will focus on the development of a Vibliome drug candidate that is a highly selective inhibitor of homeodomain-interacting protein kinase 4 (HIPK4).

November 2, 2017

·

2 min read

Business

Teleflex Reports Third Quarter 2017 Results

Third quarter 2017 net revenues were $534.7 million, an increase of 17.4% compared to the prior year period.

November 2, 2017

·

35 min read

Business

DowDuPont Reports Third Quarter 2017 Results

DowDuPont reported GAAP diluted earnings1 per share of $0.32. Pro forma adjusted earnings2 per share of $0.55 increased 10 percent compared to the year-ago period.

November 2, 2017

·

60 min read

Drug Development

BioLineRx Announces Oral Presentation at ASH of Data Supporting BL-8040 as Robust Mobilizer of Hematopoietic Stem Cells (HSC) associated With Long-Term Engraftment

The study further showed that BL-8040-mobilized HSCs can successfully engraft the bone marrow and spleen of immunodeficient mice.

November 2, 2017

·

6 min read

Drug Development

Hydra Biosciences Release: TRPC4/5 Inhibitor Now Investigated in Clinic for Central Nervous System Disorders

Hydra Biosciences announced today that Boehringer Ingelheim has initiated a Phase 1 clinical trial in healthy volunteers to evaluate a TRPC4/5 inhibitor compound for the treatment of CNS diseases and disorders including depression and anxiety.

November 2, 2017

·

3 min read

Business

Schrodinger Appoints Dov Goldstein, M.D., as CFO

Dr. Goldstein brings to Schrödinger over 20 years of strategic financial experience in the healthcare sector.

November 2, 2017

·

3 min read

BioMidwest

ResQ-Grip Glove Testing Adds Heroin Resistance

Akron Rubber Development Laboratory testing showed that a combination of heroin/fentanyl did not permeate ResQ-grip gloves up to 240 minutes of exposure.

November 2, 2017

·

1 min read